Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Kendall Forbes Sells 350,058 Shares of Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN) insider Kendall Forbes sold 350,058 shares of Guardian Pharmacy Services stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $20.16, for a total value of $7,057,169.28. Following the sale, the insider now directly owns 268,897 shares of the company’s stock, valued at approximately $5,420,963.52. This trade represents a 56.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Kendall Forbes also recently made the following trade(s):

• On Wednesday, May 28th, Kendall Forbes sold 64,991 shares of Guardian Pharmacy Services stock. The stock was sold at an average price of $20.16, for a total value of $1,310,218.56.

Guardian Pharmacy Services Stock Down 0.4%

GRDN opened at $21.37 on Friday. The business has a 50 day simple moving average of $23.14 and a two-hundred day simple moving average of $22.00. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings results on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. Research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Brown Advisory Inc. purchased a new stake in shares of Guardian Pharmacy Services in the 4th quarter worth approximately $32,294,000. Geode Capital Management LLC purchased a new stake in shares of Guardian Pharmacy Services in the 4th quarter worth approximately $4,073,000. Renaissance Technologies LLC bought a new position in Guardian Pharmacy Services in the 4th quarter valued at approximately $2,859,000. Royce & Associates LP raised its holdings in Guardian Pharmacy Services by 185.3% in the 4th quarter. Royce & Associates LP now owns 214,000 shares of the company’s stock worth $4,336,000 after purchasing an additional 139,000 shares during the period. Finally, Northern Trust Corp bought a new position in Guardian Pharmacy Services in the 4th quarter worth $1,479,000.

Analyst Ratings Changes

Several brokerages have issued reports on GRDN. Raymond James set a $28.00 price target on Guardian Pharmacy Services and gave the stock an “outperform” rating in a research note on Wednesday, May 14th. Wall Street Zen lowered Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Finally, Truist Financial reissued a “buy” rating and issued a $28.00 target price (up previously from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.